Consistent with this, our data showed that NFATc1 expression was detected in nearly all colon cancers in our cohort, and in approximately 50% of these cases NFATc1 was expressed in both nucleus and cytoplasm, and nuclear expression of NFATc1 was associated with worse survival. Here, NFATC1 is linked to colonic neoplasm.